-
Jun 29, 2026Baseline ADA Screening in Washed-Out Monkeys For Preclinical Biologics StudiesA practical overview of why baseline ADA screening is important when washed-out monkeys are reused in preclinical biologics studies, with guidance on risk assessment, animal sel... -
Jun 26, 2026Pain Mechanisms: The UVB Sunburn Model Is A Vital Translational ToolExplore how the Human UVB Sunburn Model serves as a powerful surrogate for studying peripheral and central sensitization, bridging the gap in translational pain research and ana... -
Jun 26, 2026NHP Models Of Maternal High-Fat Diet And Childhood Obesity ProgrammingDiscover how maternal and postnatal high-fat diets program energy balance and hypothalamic melanocortin signaling in non-human primate offspring. -
Jun 23, 2026Clinical Pathology Interpretation in Dogs And Nonhuman Primates in Preclinica...Understand key factors affecting clinical pathology interpretation in dogs and NHP studies, including biological variability, study design, hematology, liver, kidney, and safety... -
Jun 18, 2026Molecular Imaging Biomarkers: Advancing Translational Research And Drug Devel...Explore how molecular imaging biomarkers, including FDG PET, Amyloid PET, DAT PET, and TSPO PET, support translational research, companion diagnostics, and drug development from... -
Jun 16, 2026What Is Nonlinear Pharmacokinetics? Mechanisms, Characteristics, And Implicat...Learn what nonlinear pharmacokinetics is, why it occurs, and how saturation of ADME processes can affect drug exposure, safety, dose selection, and clinical development. -
May 21, 2026Pharmacokinetic Data As A Translational BiomarkerExplore how pharmacokinetic (PK) data function as translational biomarkers in modern drug development, CNS research, biologics, and precision medicine. -
Apr 24, 2026Non-GLP Pharmacology Studies For Regulatory Submission: Data Integrity & Labo...Learn how non-GLP pharmacology studies can support regulatory submissions through ALCOA+ data integrity, controlled laboratory practices, and translational NHP models from Prisy... -
Apr 20, 2026Strategic Design Of Nonclinical Pharmacokinetic Studies: From ADME Profiling ...Learn how to design robust nonclinical pharmacokinetic studies, including ADME profiling, dose selection, and sampling strategies. Discover how Prisys Biotech supports translati... -
Mar 10, 2026Evaluating DMPK Properties Of Candidate Compounds in Early Drug Discovery | P...Learn how key pharmacokinetic parameters—including clearance, volume of distribution, half-life, oral bioavailability, and exposure—are used to evaluate DMPK properties of candi... -
Jan 13, 2026Blood Sampling Time Point Design in Pharmacokinetic (PK) Studies | Prisys Bio...Learn how to design robust blood sampling time points for pharmacokinetic studies. This guide explains regulatory principles, phase-specific sampling strategies, and practical P... -
Jan 09, 2026PK Statistics: Non-compartmental Analysis (NCA) Parameters And Preclinical Ap...A comprehensive guide to Non-compartmental Analysis (NCA) in pharmacokinetics. Learn about key PK parameters (AUC, Cmax, CL, Vz) and their significance in preclinical NHP studie...
